Medical Condition News

RSS

New mouse brain atlas provides insight into how genes work in cerebral cortex

A new atlas of gene expression in the mouse brain provides insight into how genes work in the outer part of the brain called the cerebral cortex. In humans, the cerebral cortex is the largest part of the brain, and the region responsible for memory, sensory perception and language.

25 Aug 2011

More than eight out of 10 homeless people have at least one chronic health condition

More than eight out of 10 homeless people surveyed by researchers at St. Michael's Hospital and elsewhere have at least one chronic health condition and more than half have a mental health problem.

25 Aug 2011

Free Alzheimer's disease conference to take place on Sept. 17

University of Louisville faculty researchers and clinicians with expertise in polypharmacy, caregiving and more will join with a Washington-based geriatric researcher at a free conference examining Alzheimer's disease.

25 Aug 2011

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.

25 Aug 2011

People with Down syndrome have diminished optokinetic, vestibular reflexes

A scientist investigating why those with Down syndrome often have poor balance and motor coordination has found that key eye reflexes are substantially altered.

25 Aug 2011

US Oncology Research earns RTOG's Full Member status

US Oncology Research, one of the nation's largest networks of community-based researchers, and Radiation Therapy Oncology Group (RTOG), the leader in radiation oncology-focused clinical trials in the United States, announced today that US Oncology Research has earned Full Member status, an accomplishment few institutions achieve.

25 Aug 2011

Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company currently developing a nasal spray for the treatment of overweight and obese patients with Binge Eating Disorder, today announced that its patient testing stage of the Phase II clinical trials will start August 26th, 2011

25 Aug 2011

Repeated cocaine use can increase individual's risk of mood disorders

It is well established that a mood disorder can increase an individual's risk for substance abuse, but there is also evidence that the converse is true; substance abuse can increase a person's vulnerability to stress-related illnesses.

25 Aug 2011

ICU patients with MRSA infection may face 50% increased risk of death

Does the Methicillin-resistant Staphylococcus aureus, MRSA, cause more deaths in hospitals than the bacteria that are sensitive to common antibiotics? Opinions have been varied, but now a worldwide study at, among others, Linköping University in Sweden, indicates that the mortality rate can be 50 % higher for intensive care patients infected with MRSA.

25 Aug 2011

Amniotic fluid-derived stem cells show promise against lung disease

Two papers published in the current issue of Cell Transplantation, highlight the rich source of stem cells in human amniotic fluid that can be isolated and transplanted for therapeutic purposes.

25 Aug 2011

Study: Bone marrow transplantation may prolong period of cancer-free survival

Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.

25 Aug 2011

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Cortex Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent that protects the use of AMPAKINE molecules for the treatment or prevention of respiratory depression.

25 Aug 2011

Azithromycin can effectively reduce acute COPD exacerbations

A common antibiotic added to the usual treatment plan for some patients with chronic obstructive pulmonary disease can reduce acute exacerbations — sudden onsets of worsened cough, wheezing and labored breathing — and improve quality of life, according to findings from the COPD Clinical Research Network reported in the Aug. 25, 2011, issue of the New England Journal of Medicine.

25 Aug 2011

Patients with liver disease may now access UCSD's new Nevada clinic

Patients in Nevada seeking care for liver disease may now access the university-level expertise of UC San Diego Health System's Center for Hepatobiliary Disease and Abdominal Transplantation.

25 Aug 2011

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

25 Aug 2011

Psoriasis drug and heart attack risk association unclear: Study

According to American researchers, although a review of published studies reveals that a new and highly effective class of psoriasis drugs does not appear to raise the risk of heart problems, the studies may not have been big enough to detect rare cases.

24 Aug 2011

Britons largely unaware of risks and symptoms of bowel cancer: Survey

The latest research reveals that many people are unaware of the signs and symptoms of bowel cancer and do not know how lifestyle factors can contribute to risk.

24 Aug 2011

Parkinson’s disease breakthrough with stem cell research

A new stem cell study has raised hopes for therapy in Parkinson's disease. Researchers said they have, for the first time, generated stem cells from one of the most rapidly-progressing forms of the disease. They said the development will boost research into the condition because it will allow scientists to model the disease in laboratories and help them shed light on why certain nerve cells die. The research was led by the University of Edinburgh in collaboration with University College London (UCL).

24 Aug 2011

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Physio-Control, Inc., a global leader in emergency medical solutions and wholly‐owned subsidiary of Medtronic, Inc.,, today announced commercial availability of the ReadyLink™ 12-Lead ECG device, a new, U.S. Food and Drug Administration (FDA) 510(k)-cleared solution designed to improve care for heart attack patients and expand regional STEMI systems.

From Medtronic 24 Aug 2011

State film subsidy programs undermine longstanding tobacco control efforts

State governments, including California as well as others in Canada and the United Kingdom, pour hundreds of millions of taxpayer dollars into major motion pictures that depict smoking -- leading to thousands of new teen smokers every year, a University of California, San Francisco (UCSF) researcher has found.

24 Aug 2011